Loading news...
We believe regulatory strategy expedites development of potential first treatment to address DLB psychosis We believe regulatory strategy expedites development of potential first treatment to address DLB psychosis
Consumer confidence rebounds as inflation fears ease, spotlighting RSI, CROX, CALY, DLB and MCFT on upbeat earnings revisions.
Envestnet Asset Management Inc. decreased its holdings in shares of Dolby Laboratories (NYSE: DLB) by 9.9% in the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 129,535 shares of the electronics maker's stock after selling 14,210 shares during the
The average of price targets set by Wall Street analysts indicates a potential upside of 40.2% in Dolby Laboratories (DLB). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Cooling inflation and rising spending lift CCL, CALY, DLB and MAR as earnings estimates climb and growth outlooks brighten.
Neo Ivy Capital Management acquired 117,964 shares of DLB in the fourth quarter. The quarter-end stake value increased by $7.58 million due to the new shares acquired.
Consumer sentiment hits 6-month high as inflation hopes rise, spotlighting CCL, DLB, MAR and RL with upbeat earnings revisions on rate-cut optimism.
CHICAGO, Feb. 3, 2026 /PRNewswire/ -- Today, Source Elements announced that Source-Connect 4 has become the industry's first remote collaboration solution to achieve Dolby Atmos certification with metadata connection to the Dolby Atmos Renderer. With 128 audio streaming channels supporting any combination of beds and objects—plus full metadata integration—the update connects immersive environments like never before.
The average of price targets set by Wall Street analysts indicates a potential upside of 39% in Dolby Laboratories (DLB). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
DLB beats Q1 EPS and revenue estimates, but sales fall year over year on weaker licensing, sending shares down about 3% after hours.
Bank of New York Mellon Corp trimmed its position in shares of Dolby Laboratories (NYSE: DLB) by 0.6% in the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 5,549,482 shares of the electronics maker's stock after selling 35,447 shares
Dolby Laboratories has sold off sharply alongside the software sector, creating a more attractive entry point. Dolby maintains high gross margins, diversified licensing revenues, and capital-light operations, with recent M&A adding to its patent portfolio. AI and rapid tech innovation pose long-term risks, but current earnings and guidance show resilience.
Dolby Laboratories, Inc. (DLB) Q1 2026 Earnings Call Transcript
Although the revenue and EPS for Dolby Laboratories (DLB) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Dolby Laboratories (DLB) came out with quarterly earnings of $1.06 per share, beating the Zacks Consensus Estimate of $0.9 per share. This compares to earnings of $1.14 per share a year ago.
SAN FRANCISCO, Jan. 29, 2026 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE:DLB) today announced the company's financial results for the first quarter of fiscal 2026. "With a good start to the fiscal year, we are optimistic about our position in the market and confident in our growth opportunities," said Kevin Yeaman, President and CEO, Dolby Laboratories.
Evaluate the expected performance of Dolby Laboratories (DLB) for the quarter ended December 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Dolby Laboratories (NYSE: DLB - Get Free Report)'s stock price reached a new 52-week low during trading on Tuesday after Barrington Research lowered their price target on the stock from $95.00 to $90.00. Barrington Research currently has an outperform rating on the stock. Dolby Laboratories traded as low as $60.93 and last traded at $60.8550, with
SAN FRANCISCO, Jan. 13, 2026 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE: DLB), a leader in immersive entertainment experiences, will release financial results for the first quarter (Q1) fiscal year 2026 after the close of regular trading on Thursday, January 29, 2026. Members of Dolby management will lead a conference call open to all interested parties to discuss Q1 fiscal year 2026 financial results for Dolby Laboratories at 2:00 p.m.
Dolby Laboratories (DLB) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.